Following nerve injury neuregulin‐1 drives microglial proliferation and neuropathic pain via the MEK/ERK pathway
Open Access
- 6 January 2011
- Vol. 59 (4), 554-568
- https://doi.org/10.1002/glia.21124
Abstract
Following peripheral nerve injury microglia accumulate within the spinal cord and adopt a proinflammatory phenotype a process which contributes to the development of neuropathic pain. We have recently shown that neuregulin-1, a growth factor released following nerve injury, activates erbB 2, 3, and 4 receptors on microglia and stimulates proliferation, survival and chemotaxis of these cells. Here we studied the intracellular signaling pathways downstream of neuregulin-1-erbB activation in microglial cells. We found that neuregulin-1 in vitro induced phosphorylation of ERK1/2 and Akt without activating p38MAPK. Using specific kinase inhibitors we found that the mitogenic effect of neuregulin-1 on microglia was dependant on MEK/ERK1/2 pathway, the chemotactic effect was dependant on PI3K/Akt signaling and survival was dependant on both pathways. Intrathecal treatment with neuregulin-1 was associated with microgliosis and development of mechanical and cold pain related hypersensitivity which was dependant on ERK1/2 phosphorylation in microglia. Spinal nerve ligation results in a robust microgliosis and sustained ERK1/2 phosphorylation within these cells. This pathway is downstream of neuregulin-1/erbB signaling since its blockade resulted in a significant reduction in microglial ERK1/2 phosphorylation. Inhibition of the MEK/ERK1/2 pathway resulted in decreased spinal microgliosis and in reduced mechanical and cold hypersensitivity after peripheral nerve damage. We conclude that neuregulin-1 released after nerve injury activates microglial erbB receptors which consequently stimulates the MEK/ERK1/2 pathway that drives microglial proliferation and contributes to the development of neuropathic pain.Keywords
This publication has 85 references indexed in Scilit:
- Nrg1/ErbB signaling networks in Schwann cell development and myelinationSeminars in Cell & Developmental Biology, 2010
- Targeting Human Epidermal Growth Factor Receptor Signaling with the Neuregulin's Heparin-binding DomainPublished by Elsevier BV ,2009
- IFN-γ receptor signaling mediates spinal microglia activation driving neuropathic painProceedings of the National Academy of Sciences of the United States of America, 2009
- MAP kinase and painBrain Research Reviews, 2009
- Neuregulin-1β and neuregulin-1α differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cellsGlia, 2009
- Pathological and protective roles of glia in chronic painNature Reviews Neuroscience, 2009
- Neuron–glia crosstalk gets serious: role in pain hypersensitivityCurrent Opinion In Anesthesiology, 2008
- Neuregulin 1 in neural development, synaptic plasticity and schizophreniaNature Reviews Neuroscience, 2008
- Inhibition of spinal microglial cathepsin S for the reversal of neuropathic painProceedings of the National Academy of Sciences of the United States of America, 2007
- Phosphoproteomic analysis of Her2/neu signaling and inhibitionProceedings of the National Academy of Sciences of the United States of America, 2006